The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Metabolic network failures in Alzheimer's disease: A biochemical road map
Open accessAbstract
Introduction: The Alzheimer's Disease Research Summits of 2012 and 2015 incorporated experts from academia, industry, and nonprofit organizations to develop new research directions to transform our understanding of Alzheimer's disease (AD) and propel the development of critically needed therapies. In response to their recommendations, big data at multiple levels are being generated and integrated to study network failures in disease. We used metabolomics as a global biochemical approach to identify peripheral metabolic changes in AD patients and correlate them to cerebrospinal fluid pathology markers, imaging features, and cognitive performance. Methods: Fasting serum samples from the Alzheimer's Disease Neuroimaging Initiative (199 control, 356 mild cognitive impairment, and 175 AD participants) were analyzed using the AbsoluteIDQ‐p180 kit. Performance was validated in blinded replicates, and values were medication adjusted. Results: Multivariable‐adjusted analyses showed that sphingomyelins and ether‐containing phosphatidylcholines were altered in preclinical biomarker‐defined AD stages, whereas acylcarnitines and several amines, including the branched‐chain amino acid valine and α‐aminoadipic acid, changed in symptomatic stages. Several of the analytes showed consistent associations in the Rotterdam, Erasmus Rucphen Family, and Indiana Memory and Aging Studies. Partial correlation networks constructed for Aβ 1–42, tau, imaging, and cognitive changes provided initial biochemical insights for disease‐related processes. Coexpression networks interconnected key metabolic effectors of disease. Discussion: Metabolomics identified key disease‐related metabolic changes and disease‐progression‐related changes. Defining metabolic changes during AD disease trajectory and its relationship to clinical phenotypes provides a powerful roadmap for drug and biomarker discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Mixed-Effects Models in Sand S-PLUS
Pinheiro, J. C., & Bates, D. M. (2000) · Statistics and Computing · doi:10.1007/978-1-4419-0318-1 · Cited by 11,187
Mixed-Effects Models in S and S-PLUS
(2001) · Technometrics · doi:10.1198/tech.2001.s574 · Cited by 9,278
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143 · cited 1×
“Several ether-linked PC metabolites have been associated with the risk of diabetes [74], insulin resistance promotes aminoacidemia and the use of amino acids for energy [68], and BCAA and a-AAA have been identified as predicting diabetes risk [75,76].”
BackgroundMetabolomics: the apogee of the omics trilogy
Patti, G. J., Yanes, O., & Siuzdak, G. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3314 · Cited by 2,571
Within-subject template estimation for unbiased longitudinal image analysis
Reuter, M., Schmansky, N. J., Rosas, H. D., & Fischl, B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.084 · Cited by 2,356
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · cited 1×
“Similarly, they are found in high abundance in immune cells, are regulatory factors, and may be part of the link between inflammation and AD [65].”
BackgroundCerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Self-citationJack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042
Functions of plasmalogen lipids in health and disease
Braverman, N. E., & Moser, A. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.008 · Cited by 1,082
Alzheimer's disease: strategies for disease modification
Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,064
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Biomarker Modeling of Alzheimer’s Disease
Jack, C. R., & Holtzman, D. M. (2013) · Neuron · doi:10.1016/j.neuron.2013.12.003 · Cited by 1,002
Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988
Mixed-Effects Models in S and S-PLUS
(2000) · Statistics and Computing · doi:10.1007/b98882 · Cited by 930
Würtz, P., Havulinna, A. S., Soininen, P., Tynkkynen, T., Prieto-Merino, D., Tillin, T., Ghorbani, A., Artati, A., Wang, Q., Tiainen, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013116 · Cited by 677
Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 673
Tests for departure from normality. Empirical results for the distributions of b2 and √b1
D'AGOSTINO, R., & PEARSON, E. S. (1973) · Biometrika · doi:10.1093/biomet/60.3.613 · Cited by 606
Han, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 571
Self-citationLandau, S. M., Breault, C., Joshi, A. D., Pontecorvo, M., Mathis, C. A., Jagust, W. J., & Mintun, M. A. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109009 · Cited by 462
Brain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 461
Jones, L. L., McDonald, D. A., & Borum, P. R. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.08.004 · Cited by 454
2-Aminoadipic acid is a biomarker for diabetes risk
Wang, T. J., Ngo, D., Psychogios, N., Dejam, A., Larson, M. G., Vasan, R. S., Ghorbani, A., O’Sullivan, J., Cheng, S., Rhee, E. P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64801 · Cited by 452
Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M., & Petersen, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063644 · Cited by 438 · cited 1×
“Initial small-scale metabolomics studies in AD have highlighted metabolic alterations including ceramide–sphingomyelin pathways [10], glycerophosphatidylcholines (aa 5 diacyl, ae 5 acyl–alkyl) [PC] [15,21], PE plasmalogens [22,23], amines [24], andmitochondrial defects [25] among others [13,14].”
BackgroundHan, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429
Self-citationDavies, G., Armstrong, N., Bis, J. C., Bressler, J., Chouraki, V, Giddaluru, S., Hofer, E., Ibrahim-Verbaas, C. A., Kirin, M., Lahti, J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.188 · Cited by 384
Self-citationDiscovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers
Mittelstrass, K., Ried, J. S., Yu, Z., Krumsiek, J., Gieger, C., Prehn, C., Roemisch-Margl, W., Polonikov, A., Peters, A., Theis, F. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002215 · Cited by 383
Self-citationCOMPARE: Classification of Morphological Patterns Using Adaptive Regional Elements
Fan, Y., Shen, D., Gur, R. C., Gur, R. E., & Davatzikos, C. (2007) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2006.886812 · Cited by 366
Tests for Departure from Normality. Empirical Results for the Distributions of b 2 and √b 1
D'Agostino, R., & Pearson, E. S. (1973) · Biometrika · doi:10.2307/2335012 · Cited by 355
Acylcarnitines—old actors auditioning for new roles in metabolic physiology
McCoin, C. S., Knotts, T. A., & Adams, S. H. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.129 · Cited by 344
Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease
Whiley, L., Sen, A., Heaton, J., Proitsi, P., García-Gómez, D., Leung, R., Smith, N., Thambisetty, M., Kloszewska, I., Mecocci, P., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.001 · Cited by 340
Self-citationGaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data
Krumsiek, J., Suhre, K., Illig, T., Adamski, J., & Theis, F. J. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-21 · Cited by 323
Self-citationMetabolic Dysfunction in Alzheimers Disease and Related Neurodegenerative Disorders
Cai, H., Cong, W.-N., Ji, S., Rothman, S., Maudsley, S., & Martin, B. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015064 · Cited by 306
Gross, R. W. (1984) · Biochemistry · doi:10.1021/bi00296a026 · Cited by 297
Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases
Kaddurah-Daouk, R., & Krishnan, K. R. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.174 · Cited by 293
Self-citationde Bruijn, R. F., Bos, M. J., Portegies, M. L., Hofman, A., Franco, O. H., Koudstaal, P. J., & Ikram, M. A. (2015) · BMC Medicine · doi:10.1186/s12916-015-0377-5 · Cited by 270
Role of metabolism in neurodegenerative disorders
Procaccini, C., Santopaolo, M., Faicchia, D., Colamatteo, A., Formisano, L., de Candia, P., Galgani, M., De Rosa, V., & Matarese, G. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.018 · Cited by 258
Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014
Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., Donohue, M. C., Green, R. C., Harvey, D., Jack, C. R., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.04.005 · Cited by 239
Self-citationFrisardi, V., Panza, F., Seripa, D., Farooqui, T., & Farooqui, A. A. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.001 · Cited by 229
The Rotterdam Scan Study: design update 2016 and main findings
Ikram, M. A., van der Lugt, A., Niessen, W. J., Koudstaal, P. J., Krestin, G. P., Hofman, A., Bos, D., & Vernooij, M. W. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0105-7 · Cited by 217
Rushworth, J. V., & Hooper, N. M. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/603052 · Cited by 215
Alterations in metabolic pathways and networks in Alzheimer’s disease
Kaddurah-Daouk, R., Zhu, H., Sharma, S., Bogdanov, M., Rozen, S. G., Matson, W., Oki, N. O., Motsinger-Reif, A. A., Churchill, E., Lei, Z., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.18 · Cited by 205
Self-citationKrumsiek, J., Suhre, K., Evans, A. M., Mitchell, M. W., Mohney, R. P., Milburn, M. V., Wägele, B., Römisch-Margl, W., Illig, T., Adamski, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003005 · Cited by 197 · cited 1×
“The partial correlation networks established direct connections between the measured metabolites, which have been shown to depict direct biochemical relationships between metabolites while omitting mediated correlations [55,57].”
BackgroundSelf-citationChanges in insulin and insulin signaling in Alzheimer’s disease: cause or consequence?
Stanley, M., Macauley, S. L., & Holtzman, D. M. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160493 · Cited by 196
Patterns of cognitive function in aging: the Rotterdam Study
Hoogendam, Y. Y., Hofman, A., van der Geest, J. N., van der Lugt, A., & Ikram, M. A. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9885-4 · Cited by 195
Draisma, H. H. M., Pool, R., Kobl, M., Jansen, R., Petersen, A.-K., Vaarhorst, A. A. M., Yet, I., Haller, T., Demirkan, A., Esko, T., et al. (2015) · Nature Communications · doi:10.1038/ncomms8208 · Cited by 195
Self-citationPharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
Kaddurah-Daouk, R., & Weinshilboum, R. M. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.217 · Cited by 188
Self-citationCSF biomarkers cutoffs: The importance of coincident neuropathological diseases
Toledo, J. B., Brettschneider, J., Grossman, M., Arnold, S. E., Hu, W. T., Xie, S. X., Lee, V. M.-Y., Shaw, L. M., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0983-7 · Cited by 182 · cited 1×
“Only after substratification of the diagnostic groups (CN, MCI, and AD) based on CSF biomarkers, we were able to detect the increased values of these metabolites in participants with CSF pathology stressing the importance of using biomarkers to detect early biochemical changes [59].”
Self-citationWang, Y., Risacher, S. L., West, J. D., McDonald, B. C., MaGee, T. R., Farlow, M. R., Gao, S., O'Neill, D. P., & Saykin, A. J. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130080 · Cited by 179
Self-citationIbáñez, C., Simó, C., Martín-Álvarez, P. J., Kivipelto, M., Winblad, B., Cedazo-Mínguez, A., & Cifuentes, A. (2012) · Analytical Chemistry · doi:10.1021/ac301243k · Cited by 169
Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus
Koliaki, C., & Roden, M. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050656 · Cited by 165
Casanova, R., Varma, S., Simpson, B., Kim, M., An, Y., Saldana, S., Riveros, C., Moscato, P., Griswold, M., Sonntag, D., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.008 · Cited by 162
Self-citationMetabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine
Kaddurah‐Daouk, R., Weinshilboum, R., & on behalf of the Pharmacometabolomics Research Network (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.134 · Cited by 160
Self-citationRisacher, S. L., WuDunn, D., Pepin, S. M., MaGee, T. R., McDonald, B. C., Flashman, L. A., Wishart, H. A., Pixley, H. S., Rabin, L. A., Paré, N., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.007 · Cited by 158
Self-citationVascular disease and dementias: Paradigm shifts to drive research in new directions
Kling, M. A., Trojanowski, J. Q., Wolk, D. A., Lee, V. M. ‐., & Arnold, S. E. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.02.007 · Cited by 150
Self-citationMetabolomic changes in autopsy‐confirmed Alzheimer's disease
Kaddurah‐Daouk, R., Rozen, S., Matson, W. R., Han, X., Hulette, C. M., Burke, J. R., Doraiswamy, P. M., & Welsh-Bohmer, K. A. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.06.001 · Cited by 149
Self-citationYin, F., Yao, J., Sancheti, H., Feng, T., Melcangi, R. C., Morgan, T. E., Finch, C. E., Pike, C. J., Mack, W. J., Cadenas, E., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.013 · Cited by 136
Tests for Departure from Normality
Royston, P. J. (1992) · Stata technical bulletin · Cited by 133
Ramanan, V. K., Risacher, S. L., Nho, K., Kim, S., Shen, L., McDonald, B. C., Yoder, K. K., Hutchins, G. D., West, J. D., Tallman, E. F., et al. (2015) · Brain · doi:10.1093/brain/awv231 · Cited by 133
Self-citationAlzheimer's disease–like pathology has transient effects on the brain and blood metabolome
Pan, X., Nasaruddin, M. L., Elliott, C. T., McGuinness, B., Passmore, A. P., Kehoe, P. G., Hölscher, C., McClean, P. L., Graham, S. F., & Green, B. D. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.014 · Cited by 130
Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration
Jha, S. K., Jha, N. K., Kumar, D., Ambasta, R. K., & Kumar, P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.06.015 · Cited by 122
Ruiz, H. H., Chi, T., Shin, A. C., Lindtner, C., Hsieh, W., Ehrlich, M. E., Gandy, S., & Buettner, C. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.008 · Cited by 118
Klavins, K., Koal, T., Dallmann, G., Marksteiner, J., Kemmler, G., & Humpel, C. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.05.003 · Cited by 112
Self-citationA Network Perspective on Metabolism and Aging
Soltow, Q. A., Jones, D. P., & Promislow, D. (2010) · Integrative and Comparative Biology · doi:10.1093/icb/icq094 · Cited by 110
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease
Fiandaca, M. S., Zhong, X., Cheema, A. K., Orquiza, M. H., Chidambaram, S., Tan, M. T., Gresenz, C. R., Fitzgerald, K. T., Nalls, M. A., Singleton, A., et al. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00237 · Cited by 107
Kawaguchi, T., Nagao, Y., Matsuoka, H., Ide, T., & Sata, M. (2008) · International Journal of Molecular Medicine · doi:10.3892/ijmm.22.1.105 · Cited by 106
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans
Kang, J., Korecka, M., Figurski, M., Toledo, J. B., Blennow, K., Zetterberg, H., Waligórska, T., Brylska, M., Fields, L., Shah, N., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.003 · Cited by 104
Self-citationKoal, T., Klavins, K., Seppi, D., Kemmler, G., & Humpel, C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142319 · Cited by 103
Self-citationCross-talk of membrane lipids and Alzheimer-related proteins
Walter, J., & van Echten‐Deckert, G. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-34 · Cited by 89
Inverse-Phosphocholine Lipids: A Remix of a Common Phospholipid
Perttu, E. K., Kohli, A. G., & Szoka, F. C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210989h · Cited by 87
Fonteh, A. N., Ormseth, C. H., Chiang, J., Cipolla, M., Arakaki, X., & Harrington, M. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125597 · Cited by 74
Li, D.-N., Misialek, J. R., Boerwinkle, E., Gottesman, R., Sharrett, A., Mosley, T., Coresh, J., Wruck, L., Knopman, D., & Alonso, Á. (2016) · Alzheimer's & Dementia · doi:10.1016/j.dadm.2016.02.008 · Cited by 71
A network approach to clinical intervention in neurodegenerative diseases
Santiago, J. A., & Potashkin, J. A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.10.002 · Cited by 70
The apolipoprotein E gene and its age-specific effects on cognitive function
Liu, F., Pardo, L. M., Schuur, M., Sánchez‐Juan, P., Isaacs, A. J., Sleegers, K., de Koning, I., Zorkoltseva, I. V., Axenovich, T. I., Witteman, J. C. M., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.015 · Cited by 67
Blood metabolite markers of cognitive performance and brain function in aging
Simpson, B. N., Kim, M. G., Chuang, Y., Beason‐Held, L. L., Kitner‐Triolo, M. H., Kraut, M. A., Lirette, S. T., Windham, B. G., Griswold, M. E., Legido‐Quigley, C., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15611678 · Cited by 65
Self-citationInfluence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel
Kim, S., Swaminathan, S., Inlow, M. H., Risacher, S. L., Nho, K. T., Shen, L., Foroud, T., Petersen, R. C., Aisen, P. S. S., Soares, H. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070269 · Cited by 60
Self-citationPlasma sphingolipid changes with autopsy‐confirmed Lewy body or Alzheimer's pathology
Savica, R., Murray, M. E., Persson, X.-M. T., Kantarci, K., Parisi, J. E., Dickson, D. W., Petersen, R. C., Ferman, T. J., Boeve, B. F., & Mielke, M. M. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.02.005 · Cited by 59
Motsinger‐Reif, A. A., Zhu, H., Kling, M. A., Matson, W. R., Sharma, S., Fiehn, O., Reif, D. M., Appleby, D. H., Doraiswamy, P. M., Trojanowski, J. Q., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-28 · Cited by 54
Self-citationRelationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI
Toledo, J. B., Da, X., Bhatt, P., Wolk, D. A., Arnold, S. E., Shaw, L. M. J., Trojanowski, J. Q., Davatzikos, C. A., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055531 · Cited by 51
Self-citationGonzález‐Domínguez, R., García‐Barrera, T., Vitórica, J., & Gómez‐Ariza, J. L. (2015) · Molecular BioSystems · doi:10.1039/c4mb00747f · Cited by 50
Wood, P. L., Smith, T. M., Lane, N., Khan, M. A., Ehrmantraut, G., & Goodenowe, D. B. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-227 · Cited by 42
Cited by
Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001
Self-citationSkyline for Small Molecules: A Unifying Software Package for Quantitative Metabolomics
Adams, K. J., Pratt, B., Bose, N., Dubois, L. G., St. John-Williams, L., Perrott, K. M., Ky, K., Kapahi, P., Sharma, V., MacCoss, M. J., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00640 · Cited by 597
Self-citationAcylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M., Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000408 · Cited by 507
Varma, V. R., Oommen, A. M., Varma, S., Casanova, R., An, Y., Andrews, R. M., O’Brien, R., Pletnikova, O., Troncoso, J. C., Toledo, J., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002482 · Cited by 475
Self-citationVeitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., Cairns, N. J., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Morris, J. C., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.005 · Cited by 454
Self-citation
Metadata
- Authors
- Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., John‐Williams, L. S., MahmoudianDehkordi, S., Rotroff, D. M., Jack, J. R., Motsinger‐Reif, A., Risacher, S. L., Blach, C., Lucas, J. E., Massaro, T., Louie, G., Zhu, H., Dallmann, G., Klavins, K., Koal, T., Kim, S., Nho, K., Shen, L., Casanova, R., Varma, S., Legido‐Quigley, C., Moseley, M. A., Zhu, K., Henrion, M. Y. R., van der Lee, S. J., Harms, A. C., Demirkan, A., Hankemeier, T., van Duijn, C. M., Trojanowski, J. Q., Shaw, L. M., Saykin, A. J., Weiner, M. W., Doraiswamy, P. M., & Kaddurah‐Daouk, R.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2017-03-21
- Volume
- 13
- Issue
- 9
- Pages
- 965-984
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2603228471
- Cited by
- 468
- References
- 83
- FWCI
- 28.50
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- Funders
- National Institute on Aging (R01AG046171, RF1AG051550, 3U01AG024904‐09S4, P50 NS053488, R01 AG19771, P30 AG10133, P30 AG10124, K01 AG049050)
- U.S. National Library of Medicine (R01 LM011360, R00 LM011384)
- National Institute of Biomedical Imaging and Bioengineering (R01 EB022574)
- Alzheimer's Association
- National Institutes of Health (U01 AG024904)
- U.S. Department of Defense (W81XWH‐12‐2‐0012)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.